| 产品描述: | VEGFR-2-IN-39 (PROTAC-5) is a PROTAC targeting VEGFR-2 (IC50: 208.6 nM). VEGFR-2-IN-39 has low toxicity.VEGFR-2-IN-39 inhibits the proliferation of EA.hy926, one of HUVECs, in a concentration-dependent manner, with an IC50 of 38.65 µM. |
| 靶点: |
VEGFR2 |
| 体外研究: |
VEGFR-2-IN-39(0-60 μM; 0-72 h) 能以剂量依赖的方式有效降低 VEGFR-2 的蛋白质水平。 VEGFR-2-IN-39 (10-40 μM; 72 h) 延长 HUVEC 细胞周期的 S 期。 VEGFR-2-IN-39 (0.1-40 μM; 72 h),以剂量依赖性方式诱导 HUVEC 细胞凋亡。 |
| 参考文献: |
1. Shan Y, et al. Discovery of novel anti-angiogenesis agents. Part 11: Development of PROTACs based on active molecules with potency of promoting vascular normalization. Eur J Med Chem. 2020 Nov 1;205:112654.
|
| 保存条件: |
2-8°C, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1 ml |
4.999 ml |
9.998 ml |
| 5 mM |
0.2 ml |
1 ml |
2 ml |
| 10 mM |
0.1 ml |
0.5 ml |
1 ml |
| 50 mM |
0.02 ml |
0.1 ml |
0.2 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |